)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Utah Medical Products
Utah Medical Products (UTMD) investor relations material
Utah Medical Products Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary22 Oct, 2026
Executive summary
3Q 2026 sales fell 12.1% YoY to $8.621M; net income rose 5.9% to $2.787M and diluted EPS increased 6.8% to $0.876.
Lost PendoTECH and China distributor sales, lower Filshie demand, and weaker neonatal device sales drove declines; Orion acquisition sales and new customer wins partly offset them.
Financial highlights
9M sales declined 12.2% to $25.873M; gross profit fell 11.1% to $14.880M, operating income fell 10.6% to $8.009M, and net income fell 7.4% to $8.077M.
3Q operating income rose 7.0% to $2.795M despite gross profit decreasing 13.6% to $4.840M; lower litigation and amortization expenses offset lower sales.
Adjusted EBITDA was $3.735M, or 43.3% of sales, in 3Q and $11.303M, or 43.7%, in 9M; TTM adjusted EBITDA was $15.269M.
Outlook and guidance
FY 2026 sales are projected to decline close to 7%, versus the 12% 9M decline; projections remain uncertain.
4Q 2026 replacement sales are expected to exceed sales to the two former customers in both 4Q 2025 and 4Q 2024.
Biopharma OEM replacement sales developed more slowly than projected; the new China BPM distributor and Orion acquisition were not included in the initial outlook.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Utah Medical Products
- Sales and profits fell sharply in H1 2026, but margins and liquidity remain strong.UTMD
Q2 2026 - Revenue and net income fell, but gross margin and cash improved in Q1 2026.UTMDQ1 2026
- Board recommends electing directors, ratifying auditor, and approving executive pay at annual meeting.UTMDProxy filing
- Revenue and net income fell, but strong margins and cash enabled share buybacks and dividend growth.UTMDQ4 2025
- Annual meeting to vote on director, auditor, and executive pay, with focus on governance and compliance.UTMDProxy Filing
- Sales and earnings fell on OUS distributor cancellations and tariffs; 2025 EPS seen at $3.40–3.50.UTMDQ3 2025
- Revenue and margins fell on lower OEM sales, but cash and capital returns stayed strong.UTMDQ2 2025
- Sales and net income fell, but margins and shareholder returns stayed strong.UTMDQ3 2024
- Revenue and net income fell sharply, but liquidity and capital returns remained strong.UTMDQ1 2025
Next Utah Medical Products earnings date
Q4 202628 Jan, 2027
Utah Medical Products
Next Utah Medical Products earnings date
Q4 202628 Jan, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Utah Medical Products, Inc. (UTMD) develops, manufactures, and markets medical devices for the healthcare industry. The company specializes in products designed for critical care areas, including neonatal, obstetrics, gynecology, and general surgery. UTMD's offerings include specialty devices for labor and delivery, neonatal intensive care, and minimally invasive surgical procedures. The company is headquartered in Midvale, Utah, and its shares are listed on the NASDAQ.